Karyopharm Therapeutics Inc. (KPTI)
Market Open
11 Sep, 16:01
$
1. 31
-0.31
-19.0062%
$
38.98M Market Cap
- P/E Ratio
- Div Yield
4.45M Volume
-1.17 Eps
$ 1.62
Previous Close 
Want to track KPTI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Tops Revenue Estimates
Karyopharm Therapeutics (KPTI) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.29 per share a year ago.
Zacks | 2 years ago
